|

Comparative Effects of Alternative Nostril Breathing Versus Buteyko Breathing on Control Pause, Dyspnea and Pulmonary Function in Patients With Bronchial Asthma

RECRUITINGN/ASponsored by Foundation University Islamabad
Actively Recruiting
PhaseN/A
SponsorFoundation University Islamabad
Started2026-02-28
Est. completion2026-05-15
Eligibility
Age18 Years – 45 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07529847

Summary

Bronchial asthma is a chronic inflmmatory airway disease characterized by recurrent episodes of dyspnea, wheezing, and airflow limitation. Dysfunctional breathing pattern and chronic hyperventilation

Eligibility

Age: 18 Years – 45 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age between 18-45 years
* Both genders (male and female)
* Grade 1-3 on mMRC scale of dyspnea
* Asthma severity classes- intermediate,mild persistent and moderate persistent asthma (acc. to NAEPP National Asthma Education and Prevention Program guidlines 2020)

Exclusion Criteria:

* Patients having acute exerbation of COPD/status asthmaticus
* Patients diagnosed with acute infection
* Patients unable to follow command and instructions
* Asthma patients with \>40sec control pause duration

Conditions2

AsthmaAsthma (Diagnosis)

Browse More Trials

Asthma trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.